Fall

Oncology

32 drugs in development·11 companies·1 clinical trial

Drug Pipeline by Phase

Approved(6)

Drug	Company
Aybintio (SB8)	Organon & Co. (OGN)
elahere	ImmunoGen, Inc. (IMGN)
ibuprofen	DR REDDYS LABORATORIES LTD (RDY)
ibuprofen	PERRIGO Co plc (PRGO)
naproxen	Amneal Pharmaceuticals, Inc. (AMRX)
zejula	TESARO, Inc. (TSRO)

Phase 3(12)

Drug	Company
AZD5335	ASTRAZENECA PLC (AZN)
Background Chemotherapy	Merus N.V. (MRUS)
Ceralasertib	Relay Therapeutics, Inc. (RLAY)
Ceralasertib	ADMA BIOLOGICS, INC. (ADMA)
First-line Chemotherapy	Merus N.V. (MRUS)
Hyperthermic Intraperitoneal Chemotherapy	Merus N.V. (MRUS)
Investigator's selection of appropriate chemotherapy regimen	Merus N.V. (MRUS)
Lymphodepleting chemotherapy	Merus N.V. (MRUS)
Physician's choice chemotherapy	Merus N.V. (MRUS)
Rescue medications for chemotherapy	Merus N.V. (MRUS)
Single-agent chemotherapy	Merus N.V. (MRUS)
timing to initiate the adjuvant FOLFOX chemotherapy	Merus N.V. (MRUS)

Phase 2(2)

Drug	Company
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Olaparib	ADMA BIOLOGICS, INC. (ADMA)

Phase 1(2)

Drug	Company
Birinapant	IGM Biosciences, Inc. (IGMS)
imgn151	ImmunoGen, Inc. (IMGN)

Phase 1/Phase 2(1)

Drug	Company
Itraconazole	ASTRAZENECA PLC (AZN)

Phase 4(9)

Drug	Company
CAPOX chemotherapy	Merus N.V. (MRUS)
Chemotherapy Regimen	Merus N.V. (MRUS)
Concurrent chemotherapy	Merus N.V. (MRUS)
Conditioning chemotherapy	Merus N.V. (MRUS)
FOLFOX chemotherapy	Merus N.V. (MRUS)
Lymphodepletion Chemotherapy	Merus N.V. (MRUS)
Platinum chemotherapy	Merus N.V. (MRUS)
Single Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
Tandem 3 Cycle Intensive Chemotherapy	Merus N.V. (MRUS)

BioSniper tracks 32 drugs in development for Fall across 11 companies.

There are 1 clinical trial targeting Fall tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.